Evaluation of the Fetal MPI in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.

NCT ID: NCT03638245

Last Updated: 2018-08-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

148 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-10

Study Completion Date

2020-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester.

Study Hypothesis:

In women with non reassuring fetal cardiotocography, myocardial performance index may predict fetal distress accurately.

Study Question:

In pregnant women in the third trimester with abnormal cardiotocography, Does myocardial performance index predict fetal distress accurately?

Study Objectives:

This study aims to assess the accuracy of myocardial performance index in predicting fetal distress in pregnant women with non reassuring cardiotocography in third trimester.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Echocardiography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Abnormal CTG

This group includes pregnancies that showed abnormalities in CTG.

No interventions assigned to this group

Normal CTG

This group includes pregnancies that showed no abnormalities in CTG.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women between 30-40 weeks gestational age.
2. Women pregnant in singleton fetus.

Exclusion Criteria

1. Multiple pregnancies.
2. Fetal congenital malformation.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ali Mohamed AbdEl-Halim Ali Mehanna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ali Mohamed AbdEl-Halim Ali Mehanna

Dr

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed H Nasr El din, MD

Role: STUDY_CHAIR

Professor

Amr MA El Helaly, MD

Role: STUDY_DIRECTOR

Assistant Professor

Noha AA Sakna, MD

Role: STUDY_DIRECTOR

Lecturer

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ali MA Mehanna, MSc.

Role: CONTACT

+201116778899

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USCU 230

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Doppler Feasibility Study
NCT06093373 COMPLETED